Navigation Links
Blood Marker Suggests Severity of Alzheimer's Disease
Date:4/5/2011

By Randy Dotinga
HealthDay Reporter

TUESDAY, April 5 (HealthDay News) -- New research shows that levels of a particular protein can indicate the severity of Alzheimer's disease, but it doesn't serve as an early warning sign of the illness.

Still, the findings are helpful because they reveal that signs of Alzheimer's lurk in the blood, said one of the co-authors of the study.

"What's promising is that we can get such clear signals" through an indicator known as a biomarker, said Monique Breteler, an epidemiologist with University Medical Center Rotterdam in the Netherlands. "It will be a matter of time, and resources, to find the markers or panels of markers in blood that can be used to help predict or diagnose the disease."

Alzheimer's disease, which robs its victims of their memories, affects an estimated 5.2 million people in the United States. That number is expected to grow to as many as 7.7 million Americans by 2030 as the population ages.

At the moment, physicians can't diagnose Alzheimer's with certainty in living patients; it can only be diagnosed with certainty after death.

Scientists have known for some time that there are higher levels of a protein called clusterin in the blood of people with Alzheimer's, Breteler said, and recent research has linked variations in the protein to the disease. Those findings, in turn, raise the prospect that the protein could actually be a factor in causing Alzheimer's, she said. If so, physicians might be able to diagnose the disease early on and maybe even try to stop it in its tracks.

Unfortunately, the new study revealed the limitations of clusterin testing.

From 1997-99, researchers tested levels of the protein in 60 people with Alzheimer's and a randomly chosen group of 926 people, and additionally, in 156 people diagnosed with Alzheimer's before 2007. They found that those with the highest levels of clusterin were also most likely to have Alzheimer's even after they adjusted statistics so they wouldn't be thrown off by factors such as age, education level and gender. Alzheimer's patients with the highest levels had the worst disease.

At the moment, one potential use for a clusterin blood test would be to predict rapid decline in Alzheimer's patients, said Greg Cole, associate director of the Alzheimer's Center at the University of California Los Angeles. "But," he said, "I don't think it is ready for that use."

Dr. James R. Burke, director of the Memory Disorders Clinic at Duke University Medical Center, identified a potential problem with such a test: clusterin levels don't specify whether a person has Alzheimer's disease or vascular dementia, a form of senility related to impaired blood flow, Burke said. "So, measurements of clusterin do not appear to be useful clinically," he noted.

Even so, research like this latest study is "important to prevent widespread adoption of tests that are not useful to answer clinical questions, such as, 'Am I going to get Alzheimer's disease?'" he added.

The study appears in the April 6 issue of the Journal of the American Medical Association.

More information

For more about Alzheimer's disease, try the U.S. National Library of Medicine.

SOURCES: Monique M.B. Breteler, M.D., Ph.D., epidemiologist, University Medical Center Rotterdam, Netherlands; Greg Cole, Ph.D., professor, medicine and neurology, and associate director, Alzheimer's Center, University of California at Los Angeles, and associate director, research, Geriatric Research, Education and Clinical Center, Greater Los Angeles Veterans Administration System; James R. Burke, M.D., Ph.D., director, Memory Disorders Clinic, and associate professor, medicine, Duke University Medical Center, Durham, N.C.; April 6, 2011, Journal of the American Medical Association


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Device drops blood pressure in patients with difficult-to-treat hypertension
2. Dangerous blood pressure increases during exercise can be blocked, UT Southwestern researchers find
3. Blood Test Holds Hope for Spotting Lung Cancer in Nonsmokers
4. University of Cincinnati team to track tumor DNA through bloodstream
5. CDC issues updated bloodstream infection prevention guidelines
6. Remove childrens catheters as soon as possible to prevent bloodstream infections
7. Case study reports singing lowers patients blood pressure prior to surgery
8. Nerve Block Treatment May Ease Stubborn High Blood Pressure
9. High Blood Pressure in Docs Office Not Always Hypertension
10. Nicotine Raises Blood Sugar Levels in Lab
11. Laughter, Music May Lower Blood Pressure, Study Says
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Marker Suggests Severity of Alzheimer's Disease
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: